公开(公告)号：US20210315900A1

公开(公告)日：2021-10-14

申请号：US17349916

申请日：2021-06-17

Applicant: PFIZER INC.

Inventor： Fady Makram Louiz Ibrahim ,  Matthew Patrick Mullarney ,  Ravi M. Shanker ,  Barbara Rodriguez Spong ,  Jian Wang

IPC: A61K31/519 ,  A61K9/20 ,  A61K9/28 ,  A61K47/12 ,  A61K31/4439

Abstract: The present invention relates to solid dosage forms of palbociclib comprising a water-soluble acid. The dosage forms described herein have desirable pharmacokinetic characteristics.

公开(公告)号：US20180207100A1

公开(公告)日：2018-07-26

申请号：US15578410

申请日：2016-05-24

Applicant: PFIZER INC.

Inventor： Fady Makram Louiz Ibrahim ,  Matthew Patrick Mullarney ,  Ravi M. Shanker ,  Barbara Rodriguez Spong ,  Jian Wang

IPC: A61K9/20 ,  A61K31/519 ,  A61K9/28

CPC classification number: A61K9/2013 ,  A61K9/2009 ,  A61K9/2018 ,  A61K9/2027 ,  A61K9/205 ,  A61K9/2054 ,  A61K9/2086 ,  A61K9/2095 ,  A61K9/28 ,  A61K31/4439 ,  A61K31/519 ,  A61K47/12 ,  A61K2300/00

Abstract: The present invention relates to solid dosage forms of palbociclib comprising a water-soluble acid. The dosage forms described herein have desirable pharmacokinetic characteristics.

公开(公告)号：US11065250B2

公开(公告)日：2021-07-20

申请号：US15578410

申请日：2016-05-24

Applicant: PFIZER INC.

Inventor： Fady Makram Louiz Ibrahim ,  Matthew Patrick Mullarney ,  Ravi M. Shanker ,  Barbara Rodriguez Spong ,  Jian Wang

IPC: A61K31/519 ,  A61K9/20 ,  A61K9/28 ,  A61K47/12 ,  A61K31/4439

Abstract: The present invention relates to solid dosage forms of palbociclib comprising a water-soluble acid. The dosage forms described herein have desirable pharmacokinetic characteristics.